Open-Label Rollover Study of Levosimendan in PH-HFpEF Patients

Clinical trial NCT03624010 · COMPLETED

Trial details

NCT number: NCT03624010
Sponsor: Tenax Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hypertension Pulmonary Secondary Heart Failure Right Sided Heart Failure With Normal Ejection Fraction Heart Failure With Normal Ejection Fraction

Start date: 2019-04-09
Primary completion: 2023-04-25
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.